We apply a strategic approach built on real-world experience in big pharma and biotech.
Agility and efficiency: we identify what truly matters and act quickly to maximize team impact without compromising quality.
We communicate clearly and directly, with credibility and confidence, to provide assurance to CEOs, corporate directors, lawyers, and investors.
We simplify the complex so our clients can focus on what matters most, without wasting time or opportunities.
Biotech startups and scaleups seeking to structure strategic partnerships and ensure continuity across joint projects.
Pharma and diagnostics companies requiring efficient partner coordination and transparent governance.
Investment funds and venture capital firms requiring scientific validation and reliable milestone tracking.
Legal teams and executives requiring technical and strategic support in M&A, licensing, alliance, and collaboration agreements and disputes.
Buy- and sell-side due diligence with scientific and operational rigor, focused on risks and opportunities.
Post-M&A planning and integration to ensure synergies and operational success.
Technology transfer and asset transfer tailored to each project phase and specific needs
Optimization of pitch decks and investment narratives to attract global investors.
Investor outreach, connecting you with the right partners.
Scientific and strategic due diligence to build trust and credibility with investors.
Kickoffs and coordination of strategic collaborations.
Joint governance meetings, enabling agile and informed decision-making.
Milestone tracking and critical communications, ensuring alignment and measurable outcomes.
Pre-litigation advisory and practical dispute resolution.
Technical support in international arbitration and litigation, with a focus on M&A, alliances, licensing, and collaborations.
Proven experience in real disputes in biotech and pharma.
Reduced conflicts and misunderstandings in M&A and alliance management.
Transparency and alignment throughout all project phases.
Stronger, more reliable relationships with investors and strategic partners.
Measurable results and tangible impact, helping companies realize the full potential of their agreements and collaborations.